Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Clinical trial NCT00433511 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00433511
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-02
- Primary completion
- 2014-01-07
- Enrollment
- 4994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.